Literature DB >> 1647993

Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM.

H Maegawa1, Y Shigeta, K Egawa, M Kobayashi.   

Abstract

We studied both autophosphorylation and phosphotransferase activity of insulin receptors from abdominal skeletal muscles of nonobese subjects with non-insulin-dependent diabetes mellitus (NIDDM). Partially purified insulin receptors were labeled on their alpha-subunit with 125I-labeled insulin by chemical cross-linking and on their beta-subunit by autophosphorylation with 1000 microM ATP. Thereafter, phosphorylated insulin receptors were separated from total receptors with the anti-phosphotyrosine antibody. Thus, the percentage of phosphorylated receptors in total receptors revealed the autophosphorylation activity. Using this method, we studied the function of insulin receptors from muscle obtained by biopsy during surgery in 10 nonobese NIDDM and 8' control subjects. In diabetic subjects, insulin binding capacity from abdominal skeletal muscles was 69.4% of the control subjects. Furthermore, the percentage of phosphorylated insulin receptors stimulated by 8.3 nM insulin was significantly lower than the control subjects (mean +/- SD, 29.0 +/- 12.0 vs. 56.0 +/- 7.4%, P less than 0.01), and there was a significant inverse correlation between fasting plasma glucose levels and the percentage of phosphorylated receptors among diabetic subjects (r = 0.73, P less than 0.025). Moreover, the insulin-stimulated kinase activity toward a synthetic peptide (Glu80Tyr20) was also impaired in diabetic subjects (28.5% of control). In summary, this is the first demonstration that the autophosphorylation step of insulin receptors from abdominal skeletal muscles is impaired in nonobese NIDDM subjects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647993     DOI: 10.2337/diab.40.7.815

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

Review 1.  Insulin signaling defects in type 2 diabetes.

Authors:  Ying Leng; Håkan K R Karlsson; Juleen R Zierath
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Statin use in the metabolic syndrome.

Authors:  Justin B Lundbye; Paul D Thompson
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

Review 3.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 4.  Insulin action in skeletal muscle from patients with NIDDM.

Authors:  J R Zierath; A Krook; H Wallberg-Henriksson
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 5.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

6.  Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered.

Authors:  M Kellerer; M Coghlan; E Capp; A Mühlhöfer; G Kroder; L Mosthaf; P Galante; K Siddle; H U Häring
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients.

Authors:  H A Koistinen; A V Chibalin; J R Zierath
Journal:  Diabetologia       Date:  2003-08-23       Impact factor: 10.122

8.  Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Handberg; A Vaag; J Vinten; H Beck-Nielsen
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

9.  Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux.

Authors:  K Yoshida; J Hirokawa; S Tagami; Y Kawakami; Y Urata; T Kondo
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

Review 10.  Modulation of insulin action.

Authors:  L Pirola; A M Johnston; E Van Obberghen
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.